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Historically, all small catalytic RNAs have been shown to undergo global con-
formational changes upon phosphodiester cleavage.However, themost recent of
numerous hepatitis delta virus (HDV) ribozyme crystal structures has challenged
this trend, as this crystal structure suggests that the precursor structure is already
product-like in conformation. To further investigate this unusual observation,we
have extensively characterized the solution behavior of several three-stranded
versions of the HDV ribozyme from the recent crystal structure. Fluorescence
gel shift assays show that varying lengths of the 5’overhang sequence adjacent
to the active site result in the same degree of cleavage, whereas noncleavable
substrates exhibit significantlymore heterogeneity. Complementary steady state
and time-resolved FRET assays demonstrated that the length of the 5’overhang
sequence adjacent to the cleavage site affects the rates of conformational change
upon substrate binding and cleavage. Molecular dynamics (MD) simulations
were also performed to gain insight into the atomic behavior and catalytic rele-
vance of the HDV ribozyme from the Chen et al crystal structure. These simula-
tions suggested that the dU-1dG1dG2motif used in the crystal does not result in
a catalytically fit ribozyme compared to an all-ribose construct. Furthermore,
altered active site conditions also result in lowered catalytic fitness. These sim-
ulations suggested that catalytic fitness is greatly disrupted by deprotonation of
C75, supporting the hypothesis of the role of C75 as a general acid. Simulations
also showed that the magnesium ion resolved near the scissile phosphate results
in favorable catalytic geometry compared to simulations neutralized with so-
dium. Our experimental results demonstrate that, despite previously published
results, all forms of the HDV ribozyme undergo significant global conforma-
tional changes upon self-cleavage, and our simulations show that C75 is poised
to act as a general acid during cleavage.
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microRNA-122 (miR-122), a liver specific microRNA, has been shown to fa-
cilitate the Hepatitis C virus (HCV) replication and/or translation. Although
the exact role played by miR-122 in this process is not fully understood, it
has been shown that one of the functions of miR-122 is to stabilize the HCV
RNA genome upon binding. There are two miR-122 binding sites within the
HCV genome 5’-untranslated region (5’-UTR), named the S1 and S2 sites,
both containing the miR-122 seed sequence. It has been shown that miR-122
is a valid antiviral target, as locked nucleic acids developed against miR-122
abolished the HCV replication. However, miR-122 has numerous other func-
tions in the hepatic cell, which will also be affected by these LNAs. In this
study, we adopted a different approach, namely to design peptide nucleic acids
(PNAs) against the miR-122 binding sites within the HCV genome, sites con-
served in all HCV genotypes and to test their antiviral properties. Our results
indicate that one such PNA designed against the site S2 binds to the 5’-UTR
of the HCV genome. And moreover, has the ability to invade the miR-122/
HCV 5’UTR complex, releasing miR-122.
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Fragile X syndrome (FXS) is an inherited disease caused by a trinucleotide ex-
pansion on X the chromosome that silences the expression of the Fragile X
Mental Retardation protein (FMRP). Individuals affected by FXS show differ-
ent intensity of mental impairment and learning disabilities depending on the
mutation severity. FMRP is an RNA binding protein which has been shown
to bind to a G rich region of PSD-95 mRNA that encodes for Post Synaptic
Density Protein (PSD-95). It has been shown that in complex with a specific
microRNA (miR-125a) FMRP plays an important role in the reversible inhibi-
tion of PSD-95 mRNA translation. The loss of FMRP disables this translation
control that consecutively causes an excessive production of the PSD-95 pro-
tein. The goal of this project was to investigate at the molecular level the bio-
logical role of both FMRP and microRNA in PSD-95 mRNA translation
pathway. We have used different biophysical techniques to demonstrate thatthe PSD-95 mRNA region predicted to be bound by FMRP folds into G quad-
ruplex structures and to analyze its binding by the protein.
Voltage-gated K Channels II
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The delayed rectifier, IKr, is formed by homo/heterotetramers of the 2 HERG
splice variants HERG1a and HERG1b. The only difference between isoforms
is that HERG1b has a shorter N-terminal than HERG1a. Despite their similar-
ities, HERG1a and 1b have profoundly different gating kinetics: HERG1b has
faster activation and deactivation kinetics than HERG1a. HERG activation is
a complex multi-step process involving voltage-dependent and voltage inde-
pendent transitions.
We used an envelope of tails protocol to isolate activation from the fast over-
lapping inactivation for both HERG1a and 1b. The activation rate of both
HERG1a and 1b reaches an identical saturation value at very positive potentials,
which suggests that the voltage-independent step is rate limiting at these poten-
tials for both isoforms. This suggests that the voltage-insensitive step is not
affected by isoform, i.e., the presence or absence of the N-terminal. At lower
potentials, activation was strongly voltage dependent and was significantly dif-
ferent between isoforms. This indicates that the N-terminal modifies at least one
voltage-sensitive step in the activation pathway. Deactivation is also strongly
affected by the presence or absence of the N-terminal. This suggests that the
N-terminal affects voltage-dependent transitions near the open state. Sensitivity
analysis of our HERG model suggests that the effects may be more broad.
Manipulation of only the early states failed to optimize the rate of deactivation,
but optimization of only the final voltage dependent steps fails to recapitulate
the combination of shifted steady-state activation and slope factor for the
HERG1b isoform. In conclusion, our data indicate that the N-terminal interacts
primarily through modification of voltage-sensitive transitions.
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Ether-a-go-go (Eag) family channels are voltage-gated Kþ channels that are
important in cardiac and neural function and have a well-documented role in
disease. One of eight members of the mammalian Eag family, EAG1 channels
expression is confined to the central nervous system of the healthy adult. EAG1
channels are also expressed in cancer cells and are implicated in tumor progres-
sion and regulation of the cell cycle. Most members of the Eag channel family
exhibit voltage-dependent inactivation, yet wild-type EAG1 channels exhibit
only voltage-gated activation and deactivation, with no apparent inactivation.
Here we report that deletion of the entire intracellular amino-terminal domain
uncovers an inactivated channel gating state at depolarizing potentials. We
characterized this inactivated state in excised patches from Xenopus oocytes
expressing mutant EAG1 channels, and recorded their currents in the inside-
out configuration of the patch clamp technique. Similar to wild-type channels,
EAG1 with a deleted amino-terminus begins to activate around80 mV, how-
ever, these channels also inactivate at potentials higher than 40 mV. The rate
of inactivation becomes faster with increasingly depolarizing potentials. Addi-
tionally, the kinetics of the EAG1 channels with a deleted amino-terminus are
quite slow. Other members of the Eag family of channels exhibit C-type inac-
tivation, which results from collapse of the selectivity filter. To determine
whether the inactivation found in this EAG1 mutant was also C-type, we mu-
tated a pore-lining residue known to alter C-type inactivation in both Shaker
and hERG1 channels. As a second approach, we asked whether triethylammo-
nium applied to the external surface of the channel altered the rate of inactiva-
tion. Results from both experiments are inconsistent with C-type inactivation.
Instead, we hypothesize that inactivation in the EAG1 channel lacking their
amino-terminus is simply a reclosure of the activation gate.
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Human ether-a-go-go-related gene (hERG) potassium channels exhibit unique
kinetic properties, including unusually slow deactivation kinetics, which help
to specialize them for their role in the heart. Previously, we demonstrated
that an N-terminal eag domain is essential in regulating channel deactivation
